Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia (Q42550801)

2 November 2017

Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia (English)

1 reference

2 November 2017

1 reference

A Kontush

1

1 reference

2 November 2017

A Reich

2

1 reference

2 November 2017

K Baum

3

1 reference

2 November 2017

T Spranger

4

1 reference

2 November 2017

B Finckh

5

1 reference

2 November 2017

A Kohlschütter

6

1 reference

2 November 2017

U Beisiegel

7

1 reference

2 November 2017

1 February 1997

1 reference

2 November 2017

1 reference

2 November 2017

129

1 reference

2 November 2017

1

1 reference

2 November 2017

119-126

1 reference

Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Distribution and redox state of ubiquinones in rat and human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Antioxidant role of cellular reduced coenzyme Q homologs and alpha-tocopherol in free radical-induced injury of hepatocytes isolated from rats fed diets with different vitamin E contents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Free radicals in disease processes: a compilation of cause and consequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Low-density lipoprotein oxidation in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Analysis of lipoprotein diene formation in human serum exposed to copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Decreases in tissue levels of ubiquinol-9 and -10, ascorbate and alpha-tocopherol following spinal cord impact trauma in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Evaluation of oxidative stress in patients with hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Oxidants, antioxidants, and the degenerative diseases of aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

Lipid peroxidation: its mechanism, measurement, and significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906021-2

10.1016/S0021-9150(96)06021-2

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference